“…The association between CA125 levels and the severity of adenomyosis remains uncertain. Nonetheless, a pooled analysis of 23 documented stroke cases 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 with CA125 measurements revealed a significant increase in CA125 levels among nine individuals (cases 1, 2, 5, 10, 17–19, 21, 24) experiencing systemic embolism (defined as stroke complicating extremity or organ embolism) and/or recurrent embolism, in contrast to the 14 cases (cases 4, 6–9, 11–16, 20, 23, 25) with isolated and nonrecurrent embolism (see Figure 3 ). This preliminary investigation emphasizes the need for further research to establish the potential value of CA125 in the treatment and monitoring of thrombotic complications associated with adenomyosis.…”